Mode
Text Size
Log in / Sign up

Clinical risk factors including smoking and sleep apnea increase arrhythmia recurrence after atrial fibrillation ablationClinical risk factors linked to higher atrial fibrillation recurrence rates

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that smoking, sleep apnea, and metabolic syndrome are associated with higher arrhythmia recurrence after ablation.

The study evaluated the impact of various clinical risk factors on the rate of arrhythmia recurrence in patients undergoing catheter ablation for atrial fibrillation. The researchers analyzed a large cohort to determine how conditions such as smoking, periodontitis, metabolic syndrome, and sleep apnea influenced post-procedure outcomes.

Several factors were associated with an increased risk of arrhythmia recurrence. These included smoking, periodontitis, metabolic syndrome, and both persistent atrial fibrillation and untreated sleep apnea. Additionally, patients with uncontrolled hypertension, depression, and anxiety also showed higher rates of recurrence. The authors noted that findings regarding depression and anxiety were derived from a specific sensitivity analysis.

While the findings highlight several significant risk factors, the study notes that these results represent associations rather than direct causation. Clinicians may find these insights useful for personalized risk stratification and optimizing patient management before ablation procedures. However, the clinical application should be tempered by the understanding that these factors are associated with outcomes rather than being proven causes.

Living with atrial fibrillation, a common heart rhythm disorder, can be challenging for patients and their families. Many people undergo a procedure called catheter ablation to stop the irregular heartbeat. While this procedure is often successful, some patients find that their symptoms return over time. Understanding why the heart rhythm returns is important for doctors and patients who want to improve long-term outcomes and manage the condition more effectively.

To better understand these risks, researchers conducted a large meta-analysis. They looked at data from nearly 50,000 patients who had undergone catheter ablation for atrial fibrillation. By looking at such a large group, the researchers were able to identify specific clinical factors that might make it more likely for the arrhythmia to return after the procedure.

The study found that several specific factors were linked to a higher risk of the heart rhythm returning. For example, patients who smoked or had periodontitis (gum disease) showed a significantly higher risk of recurrence. Other factors included metabolic syndrome, untreated sleep apnea, and uncontrolled high blood pressure. Additionally, the study found that patients dealing with depression or anxiety also showed a higher risk of the heart issues returning. For instance, untreated sleep apnea was associated with a much higher risk of recurrence compared to other factors.

It is important to remember that this study shows a link between these conditions and the return of the heart rhythm, but it does not prove that one causes the other. Because this was a meta-analysis of observational data, we cannot say for certain that these factors are the direct cause of the recurrence. Furthermore, the data regarding depression and anxiety were based on a specific type of statistical analysis that may have different limitations.

For patients right now, these findings do not mean that a diagnosis of gum disease or anxiety means a procedure will fail. Instead, these results help doctors identify which patients might need extra support or more intensive management of underlying conditions before and after their procedure. By addressing these specific risk factors, medical teams can work toward better long-term results for people living with atrial fibrillation.

What this means for you:
Several conditions like sleep apnea and gum disease are linked to higher rates of heart rhythm recurrence.

Study Details

Study typeMeta analysis
Sample sizen = 49,919
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Arrhythmia recurrence after atrial fibrillation (AF) catheter ablation remains a substantial clinical challenge, but risk factors of arrhythmia recurrence are not well defined. OBJECTIVE: This study aimed to elucidate baseline clinical risk factors for postablation recurrence and variations by AF phenotype and study heterogeneity. METHODS: We systematically searched 8 databases for prospective cohort studies assessing associations between clinical risk factors and postablation arrhythmia recurrence up to 31 December 2025. Study quality was evaluated using the Newcastle-Ottawa scale. Multivariable-adjusted hazard ratios (aHRs) were pooled through random-effects meta-analyses with subgroup, meta-regression, and sensitivity analyses. RESULTS: Among 152 studies involving 49,919 patients, 16 clinical risk factors were identified. In primary meta-analysis pooling aHRs, the strongest associations were observed for smoking (aHR 2.15 [1.49-3.10)]), periodontitis (aHR 2.04 [1.48-2.83]), metabolic syndrome (aHR 1.71 [1.12-2.62]), sleep apnea (aHR 1.65 [1.31-2.09]), and persistent AF (aHR 1.64 [1.53-1.76]), followed by chronic kidney disease, alcohol consumption, overweight/obesity, diabetes mellitus, female sex, hypertension, AF history, left atrial enlargement, and impaired left ventricular ejection fraction. Untreated sleep apnea (aHR 2.41 [1.51-3.86]) and uncontrolled hypertension (aHR 1.67 [1.12-2.40]) conferred heightened risks. Sensitivity analyses pooling adjusted odds ratios (aORs) additionally identified depression (aOR 2.86 [1.51-5.41]) and anxiety (aOR 2.54 [1.59-4.04]). Subgroup analyses revealed no difference across AF phenotypes. Meta-regression identified ablation modality as a significant moderator for AF history and geographic region for female sex, heart failure, and diabetes. CONCLUSION: Expanded preablation risk profiles with consistent effect across AF phenotypes substantiate personalized risk stratification for ablation candidacy and preprocedural optimization.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.